The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2019

Filed:

Dec. 07, 2016
Applicant:

Kaleo, Inc., Richmond, VA (US);

Inventors:

Frank E. Blondino, Henrico, VA (US);

Eric S. Edwards, Moseley, VA (US);

Evan T. Edwards, Charlottesville, VA (US);

Glen L. Kelley, Glen Allen, VA (US);

Paul F. Meyers, Fishers, IN (US);

Assignee:

kaleo, Inc., Richmond, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/32 (2006.01); A61M 5/20 (2006.01); A61K 31/485 (2006.01); A61K 9/00 (2006.01); A61M 11/02 (2006.01);
U.S. Cl.
CPC ...
A61M 5/3234 (2013.01); A61K 9/0019 (2013.01); A61K 31/485 (2013.01); A61M 5/2033 (2013.01); A61M 5/2053 (2013.01); A61M 5/3287 (2013.01); A61M 11/02 (2013.01); Y02A 50/465 (2018.01);
Abstract

An apparatus includes a container, a needle, and an actuation assembly. The container contains a dose of a naloxone composition having a delivered volume of at least about 0.34 mL. The actuation assembly includes an energy storage member that produces a force on a movable member to move the needle and to deliver the dose of the naloxone composition. The 90% confidence interval of at least one of the relative mean maximum naloxone plasma concentration after dose delivery into the body (C), time to reach the maximum naloxone plasma concentration (T), area under the plasma concentration-time curve from pre-dose (time 0) extrapolated to infinity (AUC), or area under the plasma concentration-time curve from pre-dose (time 0) to the time of the last quantifiable concentration (T) (AUC) of the delivered dose to a delivered dose of a corresponding naloxone composition delivered via a manually-actuated syringe is within 80% to 125%.


Find Patent Forward Citations

Loading…